CA2309891A1 - Production de fibrinogene dans des animaux transgeniques - Google Patents

Production de fibrinogene dans des animaux transgeniques Download PDF

Info

Publication number
CA2309891A1
CA2309891A1 CA002309891A CA2309891A CA2309891A1 CA 2309891 A1 CA2309891 A1 CA 2309891A1 CA 002309891 A CA002309891 A CA 002309891A CA 2309891 A CA2309891 A CA 2309891A CA 2309891 A1 CA2309891 A1 CA 2309891A1
Authority
CA
Canada
Prior art keywords
ser
gly
lys
fibrinogen
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002309891A
Other languages
English (en)
Inventor
Ian Garner
Michael A. Dalrymple
Donna E. Prunkard
Donald C. Foster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
PPL Therapeutics Scotland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/206,176 external-priority patent/US5639940A/en
Application filed by PPL Therapeutics Scotland Ltd filed Critical PPL Therapeutics Scotland Ltd
Publication of CA2309891A1 publication Critical patent/CA2309891A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002309891A 1994-03-03 1995-03-01 Production de fibrinogene dans des animaux transgeniques Abandoned CA2309891A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/206,176 1994-03-03
US08/206,176 US5639940A (en) 1994-03-03 1994-03-03 Production of fibrinogen in transgenic animals
CA002184004A CA2184004C (fr) 1994-03-03 1995-03-01 Production de fibrinogene chez des animaux transgeniques

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002184004A Division CA2184004C (fr) 1994-03-03 1995-03-01 Production de fibrinogene chez des animaux transgeniques

Publications (1)

Publication Number Publication Date
CA2309891A1 true CA2309891A1 (fr) 1995-09-08

Family

ID=25678635

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002309891A Abandoned CA2309891A1 (fr) 1994-03-03 1995-03-01 Production de fibrinogene dans des animaux transgeniques

Country Status (1)

Country Link
CA (1) CA2309891A1 (fr)

Similar Documents

Publication Publication Date Title
CA2184004C (fr) Production de fibrinogene chez des animaux transgeniques
Clark et al. Pharmaceuticals from transgenic livestock
US5648243A (en) Human serum albumin expression construct
EP0599978A1 (fr) Gene codant une beta-caseine humaine, procede d'obtention de la proteine et son utilisation dans une formulation a usage pediatrique
CA2183546C (fr) Fibrinogene transgenique
US6545198B1 (en) Transgenically produced prolactin
WO1997020043A1 (fr) Production de proteine c chez des animaux transgeniques
CA2325871A1 (fr) Lipase humaine stimulee par le sel biliaire, produite a partir de moutons transgeniques
CA2354638A1 (fr) Expression d'alpha-foetoproteines humaines secretees chez des animaux transgeniques
EP0874898B1 (fr) Production de proteine c chez des animaux transgeniques
KR20200116044A (ko) 혈우병b 질환 모델 랫드
DEYKIN et al. RESEARCH RESULTS IN PHARMACOLOGY
Velander et al. TRANSGENIC NONHUMAN MAMMALS PRODUCING FIBRINOGEN IN MILKAND METHODS OF PRODUCING FIBRIN
WO1996040879A1 (fr) Cassettes d'adn d'expression de peptides lytiques dans des cellules de mammiferes et organismes transgeniques les contenant
CA2347579A1 (fr) Fibrinogene transgenique
Butler Production and secretion of recombinant human fibrinogen by the transgenic murine mammary gland
TW200525028A (en) Nucleic acid construct encoding hirudin and methods for producing hirudin using a transgenic mammal whose genome comprises the nucleic acid construct

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead